Diapulse Corp of America

Endorse Company
Diapulse Corporation of America is the pioneer and leader in the biophysical therapeutic effects of non-thermal pulsed electromagnetic energy in medicine. The Company manufacturers, researches and develops the proprietary Diapulse medical technology. It is indicated for the adjunctive use in the palliative treatment of postoperative edema and pain in superficial soft tissues in acute and chronic wounds. Diapulse is Medicare Covered to treat Stage III and IV pressure ulcers, venous stasis ulcers, arterial ulcers, and diabetic ulcers in Hospitals, Nursing Homes, Therapy Clinics and Physician Offices.